All authors concluded that no serious side effects were confirmed to be clearly related to the DPP-4 inhibitors, including hypoglycemia, and other causes led to discontinuation from further participation; in addition, ketoacidosis and pancreatitis were not reported. This evidence concerns the gene DPP4 and Hypoglycemia.